This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal

Arch Dermatol. 1998;134:122-123.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

PROVISIONAL surveillance data about acquired immunodeficiency syndrome (AIDS) for the first 6 months of 1996 indicated a decrease in deaths among persons with AIDS, attributed primarily to the effect of antiretroviral therapies on the survival of persons infected with human immunodeficiency virus (HIV).¹ This report describes a decline in AIDS incidence during 1996 compared with 1995 and the continued decline in AIDS deaths; the findings indicate that HIV therapies are having a widespread beneficial impact on the rate of HIV disease progression in the United States.

Cumulative AIDS cases among persons aged greater than or equal to 13 years reported to CDC through June 1997 from the 50 states, the District of Columbia, and the U.S. territories were analyzed by sex, age, race/ethnicity, and mode of risk/exposure.² Estimates of AIDS incidence and deaths were adjusted for delays in reporting. For analyses by risk/exposure, estimates were adjusted for the anticipated reclassification . . . [Full Text of this Article]

AIDS-OI Incidence


Deaths Among Persons Reported with AIDS

AIDS Prevalence
Reported by:

Editorial Note: